Browsing by Author Duehrsen, Ulrich

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)
2014Effect of Age on Efficacy and Safety Outcomes in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Receiving Lenalidomide and Low-Dose Dexamethasone (Rd): The First TrialHulin, Cyrille; Facon, Thierry; Shustik, Chaim; Belch, Andrew; Petrucci, Maria Teresa; Duehrsen, Ulrich; Lu, Jin; Song, Kevin; Rodon, Philippe; Pegourie, Brigitte; Garderet, Laurent; Hunter, Hannah; Azais, Isabelle; Eek, Richard; Macro, Margaret; Dakhil, Shaker; Houck, Vanessa; Chen, Guang; Ervin-Haynes, Annette; Offner, Fritz
2018A Global, Randomized, Placebo-Controlled, Phase 3 Study of Ibrutinib Plus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (RCHOP) in Patients with Previously Untreated Non-Germinal Center B-Cell-like (GCB) Diffuse Large B-CeYounes, Anas; Sehn, Laurie H.; Johnson, Peter; Zinzani, Pier Luigi; Hong, Xiaonan; Zhu, Jun; Samoilova, Olga; Suh, Cheolwon; Matsumura, Itaru; Lopez-Hernandez, Andres; Duehrsen, Ulrich; Thieblemont, Catherine; Carey, Jodi; Liu, Grace; Shreeve, S. Martin; Sun, Steven; Vermeulen, Jessica; Staudt, Louis M.; Wilson, Wyndham H.
2019Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell LymphomaYounes, Anas; Sehn, Laurie H.; Johnson, Peter; Zinzani, Pier Luigi; Hong, Xiaonan; Zhu, Jun; Patti, Caterina; Belada, David; Samoilova, Olga; Suh, Cheolwon; Leppae, Sirpa; Rai, Shinya; Turgut, Mehmet; Jurczak, Wojciech; Cheung, Matthew C.; Gurion, Ronit; Yeh, Su-Peng; Lopez-Hernandez, Andres; Duehrsen, Ulrich; Thieblemont, Catherine; Chiattone, Carlos Sergio; Balasubramanian, Sriram; Carey, Jodi; Liu, Grace; Shreeve, S. Martin; Sun, Steven; Zhuang, Sen Hong; Vermeulen, Jessica; Staudt, Louis M.; Wilson, Wyndham; Fisher, Richard I.; Engert, Andreas; Stadtmauer, Edward A.; Wei, Lee-Jen
2016Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST TrialHulin, Cyrille; Belch, Andrew; Shustik, Chaim; Petrucci, Maria Teresa; Duehrsen, Ulrich; Lu, Jin; Song, Kevin; Rodon, Philippe; Pegourie, Brigitte; Garderet, Laurent; Hunter, Hannah; Azais, Isabelle; Eek, Richard; Gisslinger, Heinz; Macro, Margaret; Dakhil, Shaker; Goncalves, Cristina; LeBlanc, Richard; Romeril, Ken; Royer, Bruno; Doyen, Chantal; Leleu, Xavier; Offner, Fritz; Leupin, Nicolas; Houck, Vanessa; Chen, Guang; Ervin-Haynes, Annette; Dimopoulos, Meletios A.; Facon, Thierry